(Total Views: 227)
Posted On: 01/31/2019 6:09:54 AM
Post# of 36542
I keep hearing on how we are going to finance all these acquisitions, when it was frankly stated in the Jan. 16, 2019 conference call, as well as an 8-k on Dec. 4, 2018.....we have about 25,000,000 shares left in the pool (around 61,250,000 $ from yesterday's closing of 2.45) in value.....the word "non-dilutive" was used 10 times in the conference call....i counted them....rest at peace young shareholders and old timers....we will be fine....eventually....
Excerpts from page 3 from the conference call:
I would like to take a minute to review the mechanics for the Generex pool of
shares, which we are using to complete cashless, non-dilutive acquisitions of
companies, technologies, and assets that fit our strategic plans. The Generex
pool of shares that are described in the December 4th
, 2018 AK filings have
come from four historical investors, including myself, our board member
Larry Salvo, our partner Steve Berkman, from whom we acquired HDS, and
an investment fund that have all contributed their 21 dividend shares to a
pool. All proceeds from that pool go to the benefit of Generex and its
shareholders.
These shares are available to the company for non-dilutive financing and
acquisitions, and we have used the pool to advance Veneto transactions, as
well as additional acquisitions that I will now review. Fuse Medical, as part
of our strategy to provide providers and patients end to end solutions, we are
expanding into the medical and surgical supply business to provide products,
Page 3 of 31
tools, and services for our own physician network and other providers and
hospitals. To that end, we are very happy to announce that Generex has
signed a letter of intent to acquire Fuse Medical, subject to completed due
diligence.
Excerpts from page 3 from the conference call:
I would like to take a minute to review the mechanics for the Generex pool of
shares, which we are using to complete cashless, non-dilutive acquisitions of
companies, technologies, and assets that fit our strategic plans. The Generex
pool of shares that are described in the December 4th
, 2018 AK filings have
come from four historical investors, including myself, our board member
Larry Salvo, our partner Steve Berkman, from whom we acquired HDS, and
an investment fund that have all contributed their 21 dividend shares to a
pool. All proceeds from that pool go to the benefit of Generex and its
shareholders.
These shares are available to the company for non-dilutive financing and
acquisitions, and we have used the pool to advance Veneto transactions, as
well as additional acquisitions that I will now review. Fuse Medical, as part
of our strategy to provide providers and patients end to end solutions, we are
expanding into the medical and surgical supply business to provide products,
Page 3 of 31
tools, and services for our own physician network and other providers and
hospitals. To that end, we are very happy to announce that Generex has
signed a letter of intent to acquire Fuse Medical, subject to completed due
diligence.
(0)
(0)Scroll down for more posts ▼
